An adverse drug reaction is an undesirable effect associated with the use of a drug. It may occur as a standard part of the drug's action, or it may be unpredictable.
Glossary
Adverse Drug Reaction (ADR)
02.27.12
-
Biologics, Proteins, Vaccines | cGMP Manufacture | Clinical Trial Materials | Collaborations & Alliances | Industry News | Scale-up/Technology Transfer
Merck, Stelis Open First Joint Process Scale-Up Lab in Bengaluru
Combines Stelis' bioprocess development capabilities with Merck's bioprocessing equipment
-
Breaking News | Clinical Trials | CRO News | Drug Development | Information Technology | Regulatory Affairs
BioClinica Acquires Synowledge
Adds pharmacovigilance and regulatory capabilities
-
Biosimilars | Clinical Trials | Risk Management
Growth of Biosimilars: Implications for Safety and Risk Management
Global biologics market will expand to $250 billion annually by 2020, with biosimilars and non-original biologics commanding 4-10% of that marketSuhasini Sharma, Sciformix Corporation
-
Drug Development
The Importance of Pharmacovigilance in Drug Development
Incorporating more pharmacovigilance activities into drug development and the strategies pharmaceutical companies can put in place to improve safety and prevent adverse eventsImad Alsayed and Sahil Bansal, Parexel
-
Extractables and Leachables | Facilities | GMPs/GCPs | Inspections | Methods Development | Process Development | QA/QC | Regulatory Affairs | Validation
Emerging Hotbed of Surveillance Data?
Offshoring moves to Indian shores as regulations evolveS. Harachand, Contributing Editor
